|Awarded On||February 21, 2019|
|Title||School-based Human Papillomavirus Vaccination Program in the Rio Grande Valley: Continuation and Expansion to Hidalgo County|
|Award Mechanism||Expansion of Cancer Prevention Services to Rural and Medically Underserved Populations|
|Institution/Organization||The University of Texas Medical Branch at Galveston|
|Principal Investigator/Program Director||Ana Rodriguez|
|Cancer Sites||Cervix Uteri, Head and Neck, HPV-related, Penis, Vagina, Vulva|
*Pending contract negotiation
The human papillomavirus (HPV) vaccine reduces morbidity and mortality of HPV-associated diseases (cervical, oropharyngeal, vulvar, vaginal, penile, anal cancer, anogenital warts). Because vaccinations are an effective primary prevention strategy against HPV , the overall annual direct medical cost of routine screening and treatment of HPV-associated disease ($8 billion) could be reduced if HPV vaccination rates increase.
In medically underserved areas like the Rio Grande Valley (RGV), vaccinations in non-traditional health settings (school-located mass vaccination programs, school health centers, pharmacies) can improve HPV vaccine uptake. Barriers to HPV vaccina...